Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose

NCT04226924 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Lack of funding for company

Conditions

Oculopharyngeal Muscular Dystrophy

Interventions

DRUG: Trehalose

Sponsor

Bioblast Pharma Ltd.